SGLT 2 Inhibitors; glycemic control, weight loss and safety profile in patients with type 2 Diabetes, at Medicell Institute (MIDEM).

Pak J Med Sci · 2021 · PMC7794133 · PMID 33437256

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Mean difference of HbA1c, SBP, DBP, weight, FBS from baseline to follow-up (3-6 months) was analyzed by applying paired sample T-test through SPSS v.21, considering p-value <0.001 as statistically highly significant.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.